Atheroembolic renal disease causes hypocomplementaemia.
7 patients with atheroembolic renal disease were found to have hypocomplementaemia. Evidence obtained in an experimental model of atheroembolic disease shows that the hypocomplementaemia is the result of complement activation by the atheromatous material in vivo. In addition to hypocomplementaemia, 6 patients had thrombocytopenia and 5 had eosinophilia. These observations indicate that atheroembolic disease should now be included in the differential diagnosis of hypocomplementaemia. In addition, atheroembolic disease should be considered in patients presenting with a combination of multisystem disease, hypocomplementaemia, thrombocytopenia, and eosinophilia--a syndrome which previously would have been regarded as diagnostic of immune-complex-mediated vasculitis.
Cosio
F G
FG
Zager
R A
RA
Sharma
H M
HM
D000368:Aged; D000818:Animals; D001161:Arteriosclerosis / Q000150:complications* / Q000473:pathology; D003176:Complement C3 / Q000172:deficiency; D003165:Complement System Proteins / Q000172:deficiency*; D004617:Embolism / Q000150:complications* / Q000473:pathology; D005260:Female; D006801:Humans; D007668:Kidney / Q000098:blood supply* / Q000473:pathology; D007674:Kidney Diseases / Q000150:complications* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D051381:Rats; D011919:Rats, Inbred Strains
D003176:Complement C3; D003165:Complement System Proteins